Advertisement
Canada markets open in 28 minutes
  • S&P/TSX

    21,788.48
    -60.11 (-0.28%)
     
  • S&P 500

    5,469.30
    +21.43 (+0.39%)
     
  • DOW

    39,112.16
    -299.05 (-0.76%)
     
  • CAD/USD

    0.7307
    -0.0016 (-0.22%)
     
  • CRUDE OIL

    81.20
    +0.37 (+0.46%)
     
  • Bitcoin CAD

    84,078.14
    +539.81 (+0.65%)
     
  • CMC Crypto 200

    1,272.78
    -11.01 (-0.86%)
     
  • GOLD FUTURES

    2,325.00
    -5.80 (-0.25%)
     
  • RUSSELL 2000

    2,022.35
    -8.47 (-0.42%)
     
  • 10-Yr Bond

    4.2850
    +0.0470 (+1.11%)
     
  • NASDAQ futures

    19,946.75
    -25.50 (-0.13%)
     
  • VOLATILITY

    13.11
    +0.27 (+2.10%)
     
  • FTSE

    8,217.17
    -30.62 (-0.37%)
     
  • NIKKEI 225

    39,667.07
    +493.92 (+1.26%)
     
  • CAD/EUR

    0.6840
    +0.0008 (+0.12%)
     

Balchem (NASDAQ:BCPC) jumps 3.9% this week, though earnings growth is still tracking behind five-year shareholder returns

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Balchem Corporation (NASDAQ:BCPC) share price is up 58% in the last five years, that's less than the market return. Over the last twelve months the stock price has risen a very respectable 15%.

On the back of a solid 7-day performance, let's check what role the company's fundamentals have played in driving long term shareholder returns.

Check out our latest analysis for Balchem

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

ADVERTISEMENT

Over half a decade, Balchem managed to grow its earnings per share at 7.8% a year. This EPS growth is reasonably close to the 10% average annual increase in the share price. That suggests that the market sentiment around the company hasn't changed much over that time. Indeed, it would appear the share price is reacting to the EPS.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

We know that Balchem has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for Balchem the TSR over the last 5 years was 62%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

A Different Perspective

Balchem shareholders are up 15% for the year (even including dividends). Unfortunately this falls short of the market return. On the bright side, that's still a gain, and it's actually better than the average return of 10% over half a decade This could indicate that the company is winning over new investors, as it pursues its strategy. It's always interesting to track share price performance over the longer term. But to understand Balchem better, we need to consider many other factors. To that end, you should be aware of the 1 warning sign we've spotted with Balchem .

Of course Balchem may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.